Punch & Associates Investment Management’s AbbVie ABBV Stock Holding History

Punch & Associates Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,250	Closed	-$349K	–	178
2023 Q4	$349K	Hold	2,250	–	–	0.02%	189
2023 Q3	$335K	Buy	2,250 +650	+41%	+$95.4K	0.02%	184
2023 Q2	$216K	Hold	1,600	–	–	0.01%	199
2023 Q1	$255K	Hold	1,600	–	–	0.02%	189
2022 Q4	$259K	Sell	1,600 -1,750	-52%	-$268K	0.02%	192
2022 Q3	$450K	Hold	3,350	–	–	0.03%	179
2022 Q2	$513K	Hold	3,350	–	–	0.04%	181
2022 Q1	$543K	Hold	3,350	–	–	0.03%	183
2021 Q4	$454K	Hold	3,350	–	–	0.02%	192
2021 Q3	$361K	Sell	3,350 -10	-0.3%	-$1.14K	0.02%	202
2021 Q2	$378K	Hold	3,360	–	–	0.02%	200
2021 Q1	$364K	Sell	3,360 -63	-2%	-$6.74K	0.02%	208
2020 Q4	$367K	Buy	3,423 +63	+2%	+$6.05K	0.03%	197
2020 Q3	$294K	Hold	3,360	–	–	0.03%	204
2020 Q2	$330K	Buy	3,360 +10	+0.3%	+$880	0.03%	200
2020 Q1	$255K	Buy	+3,350	New	+$285K	0.03%	197

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Punch & Associates Investment Management's ABBV Position: Q1 2024 in Review

Punch & Associates Investment Management sold out of AbbVie (ABBV) in Q1 2024, closing a stake of 2,250 shares — an estimated $349K sold.

Punch & Associates Investment Management first reported a position in ABBV in Q1 2020 and held it in 16 quarters. The position peaked at $543K in Q1 2022. 3,380 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

Punch & Associates Investment Management reported no remaining AbbVie position as of Q1 2024 after selling out during the quarter.
Punch & Associates Investment Management sold 2,250 AbbVie shares in Q1 2024, an estimated $349K.
Punch & Associates Investment Management first reported a position in AbbVie in Q1 2020 and held it in 16 quarters.
Punch & Associates Investment Management's AbbVie position peaked at $543K in Q1 2022.
3,380 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on Punch & Associates Investment Management's 13F filing for Q1 2024, filed 15 May 2024.